ALLERGY THERAPEUTICS PLC

Share Issue/Capital Change • Aug 2, 2022

National Storage Mechanism | Additional information

RNS Number : 6513U

Allergy Therapeutics PLC

02 August 2022

Allergy Therapeutics plc

Block Listing Interim Review

Date 2 August 2022

Name of applicant:		ALLERGY THERAPEUTICS PLC
Name of scheme:		Allergy Therapeutics plc 2013 Long Term Incentive Plan
Period of return:	From:	1 February 2022	To:	31 July 2022
Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:		10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017
Balance of unallotted securities under scheme(s) from previous return:		7,118,772
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period:		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		7,118,772

Name of contact:	Sara Goldsbrough
Telephone number of contact:	+44 (0) 7966 165719

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLREAFPAESKAEFA